Eluvixtamab (AMG-330)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 12:21, 4 December 2022 by Jwarner (talk | contribs) (Jwarner moved page AMG 330 to Eluvixtamab (AMG 330))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3

Retrieved from "https://hemonc.org/w/index.php?title=Eluvixtamab_(AMG-330)&oldid=64905"